CVRx (CVRX) Tariff Resilience Score: 7/10 (As of Jun. 29, 2026)


CVRX CVRx Inc CVRX
62 GF Score
Price $5.66
GF Value $11.22
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx Tariff Resilience Score?

CVRx CVRX -3.41% 62 Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus rates CVRX with a GF Score™ of 62/100 and a GF Value™ of $11.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 838 Medical Devices & Instruments companies, CVRx ranks better than 98.09% on this metric.

CVRx has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

CVRx has CVRx Inc's medical device industry benefits from some tariff exemptions. Its manufacturing is primarily domestic, reducing exposure, but it still faces risks from imported components.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes CVRx might have Highly Resilient.

CVRx  (NAS:CVRX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

CVRx Tariff Resilience Score Related Terms

CVRX vs OWLT, HYPR, MXCT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, CVRx's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CVRx Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVRx's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where CVRx's Tariff Resilience Score falls into.


CVRX
62GF Score
CVRx Inc CVRX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
CVRx (CVRX) has a Tariff Resilience Score of 7 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, CVRx ranks #16 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is CVRx's Tariff Resilience Score too high?
CVRx's current Tariff Resilience Score is 7. Based on the distribution chart, CVRx ranks #16 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CVRx has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's Tariff Resilience Score compare to OWLT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, CVRx ranks #16 out of 838 companies for Tariff Resilience Score. This places CVRx in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. CVRx's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.22, compared to a current price of $5.66 — trading 49.6% below its estimated fair value. The current Tariff Resilience Score is 7. CVRx's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For CVRx (CVRX), the current Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.66 is trading 49.6% below its estimated GF Value™ of $11.22. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • Tariff Resilience Score: 7
  • GF Value™: $11.22 vs. price of $5.66 (49.6% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
62GF Score

Get the complete analysis for CVRX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.66
Price
$11.22
GF Value